References:
  1. Toussi A, Mans N, Welborn J, and Kiuru M. Germline mutations predisposing to melanoma. J Cutan Pathol . 2020 Jul;47(7):606-616.
  2. Goldstein AM, Xiao Y, Sampson J, Zhu B, Rotunno M, Bennett H, Wen Y, Jones K, Vogt A, Burdette L, Luo W, Zhu B, Yeager M, Hicks B, Han J, De Vivo I, Koutros S, Andreotti G, Beane-Freeman L, Purdue M, Freedman ND, Chanock SJ, Tucker MA, Yang XR, Rare germline variants in known melanoma susceptibility genes in familial melanoma, Human Molecular Genetics , Volume 26, Issue 24, 15 December 2017, Pages 4886–4895.
  3. Renwick A, Thompson D, Seal S,. et al.  ATM  mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet  38, 873–875 (2006).
  4. Hall MJ, Bernhisel R, Hughes E, Larson K. Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM ) Gene are Associated with High and Moderate Risks for Multiple Cancers. Cancer Prevention Research. (2021) 14 (4): 433-440.
  5. NCCN Clinical Practice Guidelines in Oncology®: Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 3.2019.
  6. Navid F, Herzog CE, Sandoval J, et al. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatr Blood Cancer 2016:63(7):1207–1213
  7. Chang W, Brohl AS, Patidar R, et al. Multidimensional ClinOmics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: a report from the center for cancer research. Clin Cancer Res. 2016;22(15):3810‐3820.
  8. Everett JN, Mody RJ, Stoffel EM, Chinnaiyan AM. Incorporating genetic counseling into clinical care for children and adolescents with cancer. Future Oncol. 2016;17(7):883‐886
  9. Parsons DW, Roy A, Yang Y, et al.Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. JAMA Oncol 2 (5): 616-624, 2016.
  10. Zhang J, Walsh MF, Wu G, et al.Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med 373 (24): 2336-46, 2015
  11. Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, Novokmet A, Finlay J, Malkin D. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 2011 Jun;12(6):559-67.
  12. Schneider K, Zelley K, Nichols KE, et al. Li-Fraumeni Syndrome. 1999 Jan 19 [Updated 2019 Nov 21]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.
  13. Aronson M, Colas C, Shuen A, Hampel H, Foulkes WD, Feldman HB, Goldberg Y, Muleris M, Schneider KW, McGee RB, Jasperson K, Rangaswami A, Brugieres L, Tabori U. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group. Journal of Medical Genetics  2022;59:318-327.
  14. Koolen DA, Morgan A, de Vries BBA. Koolen-de Vries Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al. GeneReviews® . Seattle (WA): University of Washington, Seattle; January 26, 2010.
  15. Tabori U, Hansford RJ, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugireres L. Clinical Management and Tumor Surveillance Recommendation of Inherited Mismatch Repair Deficiency in Childhood. Clinical Cancer Research. (2017) 23 (11);e32-e37.
  16. Dalmasso B, Pastorino L, Nathan V, et al. Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia. Genetics in Medicine. Volume 23, Issue 11 2021 (2087-2095. 1098-3600
  17. Tuominen R, Engström PG, Helgadottir H, et al. The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility. Genes Chromosomes Cancer . 2016;55(7):601-611. doi:10.1002/gcc.22363
  18. Pellegrini C, Raimondi S, Di Nardo L, et al. Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. J Eur Acad Dermatol Venereol . 2022;36(2):213-221.doi:10.1111/jdv.17735